Aerovate Therapeutics, Inc.

NASDAQ:AVTE

2.68 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -2.518-5.43-16.237-24.775-23.186-20.413-19.563-19.025-16.52-15.022-13.588-11.991-10.91-8.223-6.184-5.775-2.781-3.666-2.307-2.202-1.436
Depreciation & Amortization -0.2210.008-1.6940.0280.0280.0280.0250.0220.0210.020.020.0170.0110.0080.0030.0020.0020.001000
Deferred Income Tax 00000-4.351000000000000000
Stock Based Compensation 1.1851.2432.0033.8654.23.2513.2373.0342.3841.7291.4991.2241.0240.8540.8450.3210.0230.0240.0210.0060.007
Change In Working Capital 0-6.1042.8151.141-3.9563.2731.4981.6653.362-1.0062.6411.9354.185-5.748-1.191.447-1.0190.757-0.2110.260.168
Accounts Receivables 000000000000000000000
Change In Inventory 000000000000000000000
Change In Accounts Payables -0.1550-3.2710.9480.835-1.044-2.0140.7732.121-1.7492.242-0.7121.587-1.0451.091-0.2020.7650.007-0.0990.0380.091
Other Working Capital 0-6.1046.0860.193-4.7914.3173.5120.8921.2410.7430.3992.6472.598-4.703-2.2811.649-1.7840.75-0.1120.2220.077
Other Non Cash Items -0.827-0.764-2.93-0.6922.6623.412-0.808-0.639-0.671-0.586-0.292-0.0610.0290.016-0.240.527-0.7380.0070.0640.5770.078
Operating Cash Flow -2.381-11.047-16.043-20.433-23.673-14.8-15.611-14.943-11.424-14.865-9.72-8.876-5.661-13.093-6.526-4.005-3.775-2.884-2.433-1.359-1.183
Investing Activities:
Investments In Property Plant And Equipment 00000-0.064-0.032-0.03-0.016-0.004-0.033-0.13-0.028-0.085-0.0560-0.040000
Acquisitions Net 00000-0.0060.013-0.004-0.015-0.014-0.005-0.008000000000
Purchases Of Investments 00-4.9330-14.75-27.788-47.848-32.737-15.609-50.26-25.572-38.901-32.89-113.2530000000
Sales Maturities Of Investments 12.850211823.58333.534.7536.753164.7530.2547.22512.51900000000
Other Investing Activites 013.129008.8330.006-0.0130.0040.0150.0140.0050.008-20.371-113.2530000000
Investing Cash Flow 12.8513.12916.067188.8335.648-13.133.98315.37514.4864.6458.194-20.399-113.338-0.0560-0.040000
Financing Activities:
Debt Repayment 000000000000000000000
Common Stock Issued 00.307-1.21624.380.4710.4630.0245.290.2230.150.0370.0020-0.25128.3154.5147.8830000
Common Stock Repurchased 000000000000000000000
Dividends Paid 000000000000000000000
Other Financing Activities 00.2470.02224.380.4710.4630.0245.290.2230.3570.0370.00200128.3154.5147.88308.91800
Financing Cash Flow 00.5540.02224.380.4710.4630.0245.290.2230.3570.0370.0020-0.25128.3154.5147.88308.91800
Other Information:
Effect Of Forex Changes On Cash 000000000000000000000
Net Change In Cash 10.4692.6360.04621.947-14.369-8.689-28.72134.334.174-0.022-5.038-0.68-26.06-126.681121.72850.5094.068-2.8846.485-1.359-1.183
Cash At End Of Period 44.2233.75131.11531.0699.12223.49132.1860.90126.57122.39722.41927.45728.13754.197180.87859.158.6414.5737.4570.9722.331